The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Oral Peptide Drug Market Research Report 2024

Global Oral Peptide Drug Market Research Report 2024

Publishing Date : Feb, 2024

License Type :
 

Report Code : 1689057

No of Pages : 70

Ask Your Query
Synopsis
The drugs give through oral.

The global Oral Peptide Drug market was valued at US$ 2000 million in 2023 and is anticipated to reach US$ 7980.1 million by 2030, witnessing a CAGR of 15.0% during the forecast period 2024-2030.

The Peptide Drug market is driven by the increasing recognition of peptides as a versatile and promising class of therapeutics. Peptides offer the potential to target specific biological pathways and cellular functions with high specificity, making them valuable candidates for treating a wide range of diseases, including cancer, metabolic disorders, and cardiovascular conditions. The growing understanding of peptide structure-activity relationships, coupled with advancements in peptide synthesis and modification techniques, contribute to the development of more stable and bioavailable peptide drugs, fostering market growth. Moreover, the rise in personalized medicine approaches and the need for more targeted therapies align with the development of peptide-based treatments that can be tailored to individual patient profiles. However, the market also faces challenges, including optimizing peptide delivery systems, enhancing bioavailability, and addressing potential immunogenicity and stability issues. Additionally, the complexity of peptide synthesis, the need for stringent regulatory approvals, and the competition from other therapeutic modalities pose obstacles for manufacturers and researchers. To succeed, stakeholders must focus on innovative peptide design, efficient synthesis methods, and comprehensive pre-clinical and clinical studies to demonstrate the safety and efficacy of peptide drugs. Addressing challenges while harnessing the therapeutic potential of peptides will be essential for driving the growth and adoption of peptide-based treatments in various medical applications.

This report aims to provide a comprehensive presentation of the global market for Oral Peptide Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Peptide Drug.

Report Scope

The Oral Peptide Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Peptide Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Peptide Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

Allergan

Novo Nordisk

Synergy Pharmaceuticals （Salix）

Novartis

Chiasma

Segment by Type

Linaclotide

Insulin

Plecanatide

Cyclosporine

Octreotide

Segment by Application

Hospital

Retail Pharmacy

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Peptide Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oral Peptide Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Linaclotide

1.2.3 Insulin

1.2.4 Plecanatide

1.2.5 Cyclosporine

1.2.6 Octreotide

1.3 Market by Application

1.3.1 Global Oral Peptide Drug Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oral Peptide Drug Market Perspective (2019-2030)

2.2 Oral Peptide Drug Growth Trends by Region

2.2.1 Global Oral Peptide Drug Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Oral Peptide Drug Historic Market Size by Region (2019-2024)

2.2.3 Oral Peptide Drug Forecasted Market Size by Region (2025-2030)

2.3 Oral Peptide Drug Market Dynamics

2.3.1 Oral Peptide Drug Industry Trends

2.3.2 Oral Peptide Drug Market Drivers

2.3.3 Oral Peptide Drug Market Challenges

2.3.4 Oral Peptide Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oral Peptide Drug Players by Revenue

3.1.1 Global Top Oral Peptide Drug Players by Revenue (2019-2024)

3.1.2 Global Oral Peptide Drug Revenue Market Share by Players (2019-2024)

3.2 Global Oral Peptide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Oral Peptide Drug Revenue

3.4 Global Oral Peptide Drug Market Concentration Ratio

3.4.1 Global Oral Peptide Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oral Peptide Drug Revenue in 2023

3.5 Oral Peptide Drug Key Players Head office and Area Served

3.6 Key Players Oral Peptide Drug Product Solution and Service

3.7 Date of Enter into Oral Peptide Drug Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Peptide Drug Breakdown Data by Type

4.1 Global Oral Peptide Drug Historic Market Size by Type (2019-2024)

4.2 Global Oral Peptide Drug Forecasted Market Size by Type (2025-2030)

5 Oral Peptide Drug Breakdown Data by Application

5.1 Global Oral Peptide Drug Historic Market Size by Application (2019-2024)

5.2 Global Oral Peptide Drug Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Oral Peptide Drug Market Size (2019-2030)

6.2 North America Oral Peptide Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Oral Peptide Drug Market Size by Country (2019-2024)

6.4 North America Oral Peptide Drug Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oral Peptide Drug Market Size (2019-2030)

7.2 Europe Oral Peptide Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Oral Peptide Drug Market Size by Country (2019-2024)

7.4 Europe Oral Peptide Drug Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oral Peptide Drug Market Size (2019-2030)

8.2 Asia-Pacific Oral Peptide Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Oral Peptide Drug Market Size by Region (2019-2024)

8.4 Asia-Pacific Oral Peptide Drug Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oral Peptide Drug Market Size (2019-2030)

9.2 Latin America Oral Peptide Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Oral Peptide Drug Market Size by Country (2019-2024)

9.4 Latin America Oral Peptide Drug Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oral Peptide Drug Market Size (2019-2030)

10.2 Middle East & Africa Oral Peptide Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Oral Peptide Drug Market Size by Country (2019-2024)

10.4 Middle East & Africa Oral Peptide Drug Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Allergan

11.1.1 Allergan Company Detail

11.1.2 Allergan Business Overview

11.1.3 Allergan Oral Peptide Drug Introduction

11.1.4 Allergan Revenue in Oral Peptide Drug Business (2019-2024)

11.1.5 Allergan Recent Development

11.2 Novo Nordisk

11.2.1 Novo Nordisk Company Detail

11.2.2 Novo Nordisk Business Overview

11.2.3 Novo Nordisk Oral Peptide Drug Introduction

11.2.4 Novo Nordisk Revenue in Oral Peptide Drug Business (2019-2024)

11.2.5 Novo Nordisk Recent Development

11.3 Synergy Pharmaceuticals （Salix）

11.3.1 Synergy Pharmaceuticals （Salix） Company Detail

11.3.2 Synergy Pharmaceuticals （Salix） Business Overview

11.3.3 Synergy Pharmaceuticals （Salix） Oral Peptide Drug Introduction

11.3.4 Synergy Pharmaceuticals （Salix） Revenue in Oral Peptide Drug Business (2019-2024)

11.3.5 Synergy Pharmaceuticals （Salix） Recent Development

11.4 Novartis

11.4.1 Novartis Company Detail

11.4.2 Novartis Business Overview

11.4.3 Novartis Oral Peptide Drug Introduction

11.4.4 Novartis Revenue in Oral Peptide Drug Business (2019-2024)

11.4.5 Novartis Recent Development

11.5 Chiasma

11.5.1 Chiasma Company Detail

11.5.2 Chiasma Business Overview

11.5.3 Chiasma Oral Peptide Drug Introduction

11.5.4 Chiasma Revenue in Oral Peptide Drug Business (2019-2024)

11.5.5 Chiasma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details
List of Tables
List of Tables

Table 1. Global Oral Peptide Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Linaclotide

Table 3. Key Players of Insulin

Table 4. Key Players of Plecanatide

Table 5. Key Players of Cyclosporine

Table 6. Key Players of Octreotide

Table 7. Global Oral Peptide Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Oral Peptide Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Oral Peptide Drug Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Oral Peptide Drug Market Share by Region (2019-2024)

Table 11. Global Oral Peptide Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Oral Peptide Drug Market Share by Region (2025-2030)

Table 13. Oral Peptide Drug Market Trends

Table 14. Oral Peptide Drug Market Drivers

Table 15. Oral Peptide Drug Market Challenges

Table 16. Oral Peptide Drug Market Restraints

Table 17. Global Oral Peptide Drug Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Oral Peptide Drug Market Share by Players (2019-2024)

Table 19. Global Top Oral Peptide Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Peptide Drug as of 2023)

Table 20. Ranking of Global Top Oral Peptide Drug Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Oral Peptide Drug Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Oral Peptide Drug Product Solution and Service

Table 24. Date of Enter into Oral Peptide Drug Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Oral Peptide Drug Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Oral Peptide Drug Revenue Market Share by Type (2019-2024)

Table 28. Global Oral Peptide Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Oral Peptide Drug Revenue Market Share by Type (2025-2030)

Table 30. Global Oral Peptide Drug Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Oral Peptide Drug Revenue Market Share by Application (2019-2024)

Table 32. Global Oral Peptide Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Oral Peptide Drug Revenue Market Share by Application (2025-2030)

Table 34. North America Oral Peptide Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Oral Peptide Drug Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Oral Peptide Drug Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Oral Peptide Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Oral Peptide Drug Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Oral Peptide Drug Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Oral Peptide Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Oral Peptide Drug Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Oral Peptide Drug Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Oral Peptide Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Oral Peptide Drug Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Oral Peptide Drug Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Oral Peptide Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Oral Peptide Drug Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Oral Peptide Drug Market Size by Country (2025-2030) & (US$ Million)

Table 49. Allergan Company Detail

Table 50. Allergan Business Overview

Table 51. Allergan Oral Peptide Drug Product

Table 52. Allergan Revenue in Oral Peptide Drug Business (2019-2024) & (US$ Million)

Table 53. Allergan Recent Development

Table 54. Novo Nordisk Company Detail

Table 55. Novo Nordisk Business Overview

Table 56. Novo Nordisk Oral Peptide Drug Product

Table 57. Novo Nordisk Revenue in Oral Peptide Drug Business (2019-2024) & (US$ Million)

Table 58. Novo Nordisk Recent Development

Table 59. Synergy Pharmaceuticals （Salix） Company Detail

Table 60. Synergy Pharmaceuticals （Salix） Business Overview

Table 61. Synergy Pharmaceuticals （Salix） Oral Peptide Drug Product

Table 62. Synergy Pharmaceuticals （Salix） Revenue in Oral Peptide Drug Business (2019-2024) & (US$ Million)

Table 63. Synergy Pharmaceuticals （Salix） Recent Development

Table 64. Novartis Company Detail

Table 65. Novartis Business Overview

Table 66. Novartis Oral Peptide Drug Product

Table 67. Novartis Revenue in Oral Peptide Drug Business (2019-2024) & (US$ Million)

Table 68. Novartis Recent Development

Table 69. Chiasma Company Detail

Table 70. Chiasma Business Overview

Table 71. Chiasma Oral Peptide Drug Product

Table 72. Chiasma Revenue in Oral Peptide Drug Business (2019-2024) & (US$ Million)

Table 73. Chiasma Recent Development

Table 74. Research Programs/Design for This Report

Table 75. Key Data Information from Secondary Sources

Table 76. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Oral Peptide Drug Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Oral Peptide Drug Market Share by Type: 2023 VS 2030

Figure 3. Linaclotide Features

Figure 4. Insulin Features

Figure 5. Plecanatide Features

Figure 6. Cyclosporine Features

Figure 7. Octreotide Features

Figure 8. Global Oral Peptide Drug Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Oral Peptide Drug Market Share by Application: 2023 VS 2030

Figure 10. Hospital Case Studies

Figure 11. Retail Pharmacy Case Studies

Figure 12. Oral Peptide Drug Report Years Considered

Figure 13. Global Oral Peptide Drug Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Oral Peptide Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Oral Peptide Drug Market Share by Region: 2023 VS 2030

Figure 16. Global Oral Peptide Drug Market Share by Players in 2023

Figure 17. Global Top Oral Peptide Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Peptide Drug as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Oral Peptide Drug Revenue in 2023

Figure 19. North America Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Oral Peptide Drug Market Share by Country (2019-2030)

Figure 21. United States Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Oral Peptide Drug Market Share by Country (2019-2030)

Figure 25. Germany Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Oral Peptide Drug Market Share by Region (2019-2030)

Figure 33. China Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Oral Peptide Drug Market Share by Country (2019-2030)

Figure 41. Mexico Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Oral Peptide Drug Market Share by Country (2019-2030)

Figure 45. Turkey Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Oral Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Allergan Revenue Growth Rate in Oral Peptide Drug Business (2019-2024)

Figure 48. Novo Nordisk Revenue Growth Rate in Oral Peptide Drug Business (2019-2024)

Figure 49. Synergy Pharmaceuticals （Salix） Revenue Growth Rate in Oral Peptide Drug Business (2019-2024)

Figure 50. Novartis Revenue Growth Rate in Oral Peptide Drug Business (2019-2024)

Figure 51. Chiasma Revenue Growth Rate in Oral Peptide Drug Business (2019-2024)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock